Merck and Moderna’s Intismeran Autogene Plus Keytruda Meets Phase 3 RFS and DMFS Endpoints in Resected Melanoma
FDA Grants HDE Approval to OncoSil for Distal Cholangiocarcinoma
FDA Lists More Than 1,500 AI-Enabled Medical Devices as Oncology Applications Expand
oncoHUB and OncoDaily Announce Strategic Partnership to Strengthen Ukrainian Oncology
Human Connection in Cancer Care with Dr. Aleksandra Filipovic - CancerWorld
Bridging the Care Gap: Expanding Humanitarian Access to CLL Treatment Across LMICs
Simplify Your ESO College Enrolment With Our New 3-Year Plan - ESO
ENZAMET: Enzalutamide Maintains Long-Term Survival Benefit in mHSPC
The Advancing Bioequivalence Frameworks for Inhalation Drug Products: Optimizing In Vitro, In Vivo, and In Silico Methods workshop, co-hosted by the U.S. Food and Drug Administration (FDA) and the Center for Research on Complex Generics (CRCG), will take place on October 14–15, 2026, in Rockville, Maryland, with both in-person and virtual attendance available. The two-day […]
